Author

Minhu Chen

EFFICACY AND SAFETY OF UPADACITINIB INDUCTION THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE: RESULTS FROM A RANDOMIZED PHASE 3 U-EXCEL STUDY
EFFICACY AND SAFETY OF UPADACITINIB INDUCTION THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE: RESULTS FROM A RANDOMIZED PHASE 3 U-EXCEL STUDY

Minhu Chen  et al.

THE EFFECT OF GUSELKUMAB INDUCTION THERAPY ON INFLAMMATORY BIOMARKERS IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: QUASAR PHASE 2B INDUCTION RESULTS THROUGH WEEK 12
THE EFFECT OF GUSELKUMAB INDUCTION THERAPY ON INFLAMMATORY BIOMARKERS IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: QUASAR PHASE 2B INDUCTION RESULTS THROUGH WEEK 12

Minhu Chen  et al.

A CHINESE SUBGROUP ANALYSIS OF THE ASIAN PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF VONOPRAZAN 10 OR 20 MG COMPARED WITH LANSOPRAZOLE 15 MG IN THE MAINTENANCE TREATMENT OF ASIAN PATIENTS WITH EROSIVE ESOPHAGITIS
A CHINESE SUBGROUP ANALYSIS OF THE ASIAN PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF VONOPRAZAN 10 OR 20 MG COMPARED WITH LANSOPRAZOLE 15 MG IN THE MAINTENANCE TREATMENT OF ASIAN PATIENTS WITH EROSIVE ESOPHAGITIS

Minhu Chen  et al.

THE EFFICACY AND SAFETY OF H008 COMPARED WITH LANSOPRAZOLE IN PATIENTS WITH DUODENAL ULCER (DU): A PHASE II, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL MULTICENTER STUDY IN CHINA
THE EFFICACY AND SAFETY OF H008 COMPARED WITH LANSOPRAZOLE IN PATIENTS WITH DUODENAL ULCER (DU): A PHASE II, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL MULTICENTER STUDY IN CHINA

Minhu Chen  et al.

THE EFFICACY AND SAFETY OF KEVERPRAZAN (H008) IN THE TREATMENT OF DUODENAL ULCER: A MULTICENTERED, RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROL TRIAL IN CHINA
THE EFFICACY AND SAFETY OF KEVERPRAZAN (H008) IN THE TREATMENT OF DUODENAL ULCER: A MULTICENTERED, RANDOMIZED, DOUBLE-BLIND, ACTIVE-CONTROL TRIAL IN CHINA

Minhu Chen  et al.

Item 1 - 5 / 5
1